Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1111/jth.15291 http://scihub22266oqcxt.onion/10.1111/jth.15291 33783953!8250362!33783953     free     free     free Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       J+Thromb+Haemost 2021 ; 19 (6): 1515-1518 Nephropedia Template TP {{tp|p=33783953|t=2021. A case report of acquired hemophilia following COVID-19 vaccine |pdf=|usr=}}{{33783953}} gab.com Text A case report of acquired hemophilia following COVID-19 vaccine JO: J Thromb Haemost http://www.kidney.de/pget.php?&tw=1&pmid=33783953 #FOAvip Acquires hemophilia A (AHA) is rare bleeding condition commonly associated with malignancy, autoimmune disease, or pregnancy. We report a case of a 69-year-old gentleman who developed bleeding symptoms after receiving COVID-19 vaccine. Laboratory testing showed isolated prolongation of the activated partial thromboplastin time, and normal von Willebrand factor. Further testing confirmed the presence of factor VIII inhibitor. To date, no cases of AHA have been reported after exposure to COVID-19 vaccine. There have been two cases of AHA following seasonal flu and H1N1 vaccination, as well as two cases of AHA following COVID-19 infection. We present a summary of these cases and review of literature of autoimmune reactions following vaccination. Twit Text FOAVip A case report of acquired hemophilia following COVID-19 vaccine ????J Thromb Haemost http://www.kidney.de/pget.php?&tw=1&pmid=33783953 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=33783953 #FOAvip English Wikipedia <ref>{{Cite pmid|33783953}}</ref> A case report of acquired hemophilia following COVID-19 vaccine #MMPMID33783953 Radwi M; Farsi S J Thromb Haemost 2021[Jun]; 19 (6): 1515-1518 PMID33783953show ga Acquires hemophilia A (AHA) is rare bleeding condition commonly associated with malignancy, autoimmune disease, or pregnancy. We report a case of a 69-year-old gentleman who developed bleeding symptoms after receiving COVID-19 vaccine. Laboratory testing showed isolated prolongation of the activated partial thromboplastin time, and normal von Willebrand factor. Further testing confirmed the presence of factor VIII inhibitor. To date, no cases of AHA have been reported after exposure to COVID-19 vaccine. There have been two cases of AHA following seasonal flu and H1N1 vaccination, as well as two cases of AHA following COVID-19 infection. We present a summary of these cases and review of literature of autoimmune reactions following vaccination. |*COVID-19[MESH] |*Hemophilia A/diagnosis[MESH] |*Influenza A Virus, H1N1 Subtype[MESH] |Aged[MESH] |COVID-19 Vaccines[MESH] |Factor VIII[MESH] |Female[MESH] |Humans[MESH] |Male[MESH] |Pregnancy[MESH]A case report of acquired hemophilia following COVID-19 vaccine (epmc).pdf DeepDyve Pubget Overpricing